Priority Date: 08.09.08 (EP 20080163879)

PYRAZOLOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CNS DISORDERS

  • Application ID: EP09782607
  • Status: The patent has been granted

Applicant

Attorneys

no operation time available
2 offices
Technology Company
no operation time available
2 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Boehringer Ingelheim GmbH is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 233 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 08.09.2008 - Priority Date (EP 20080163879)
  • 11.03.2010 - Publication A1 (WO2010026214)
  • 22.06.2011 - Publication A1 (EP2334684)
  • 02.08.2017 - Publication B1 (EP2334684)